NCT05929235 2026-01-30A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial CarcinomaFlare Therapeutics Inc.Phase 1 Recruiting120 enrolled
NCT05318573 2025-09-04A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung CancerFujifilm Pharmaceuticals U.S.A., Inc.Phase 2 Active not recruiting120 enrolled